Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
m-FLAI in elderly AML
NCT01247493Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jun 2007
- Primary completion
- Jun 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fludarabine, cytarabine and idarubicin in acute myeloid leukemia (AML), sponsored by Seoul National University Hospital. Primary endpoint: Complete Remission Rate. Started Jun 2007; status: completed.
02
Drugs
fludarabinecytarabineidarubicin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01247493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01247493.